ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Order Full text via Infotrieve
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Finnerty, J.
Right arrow Articles by Holgate, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Finnerty, J.
Right arrow Articles by Holgate, S.
Eur Respir J 1990; 3: 540-547
Copyright © ERS Journals Ltd 1990


Clinical Trial

Evidence for the roles of histamine and prostaglandins as mediators in exercise-induced asthma: the inhibitory effect of terfenadine and flurbiprofen alone and in combination

JP Finnerty and ST Holgate

We investigated the effects of terfenadine, a histamine H1-receptor antagonist, and flurbiprofen, a cyclooxygenase inhibitor, on exercise-induced bronchoconstriction to assess the contribution of the mast cell products histamine and prostaglandins. Eight asthmatics were studied on 4 occasions with treadmill exercise tests. Terfenadine or placebo was administered 3 h prior to exercise, and flurbiprofen or placebo was administered 2 h prior to exercise, in a double-blind randomized trial. Airway calibre was determined by measurement of the forced expiratory volume in one second (FEV1) immediately prior to exercise challenge, and over 30 min post-exercise. Following placebo, the mean maximum percentage fall in FEV1 was 39%. This fell to 25% after terfenadine (p less than 0.05), 27% after flurbiprofen (p less than 0.05), and 30% after the active combination (NS). Analysis of the areas under curves of percentage falls in FEV1 over 30 min showed significant inhibition on all 3 active drug days (p less than 0.05). We conclude that histamine release and prostaglandin generation contribute to exercise-induced bronchoconstriction, although the interaction between these mediators appears complex.


This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
M. S. Davis, J. R. Malayer, L. Vandeventer, C. M. Royer, E. C. McKenzie, and K. K. Williamson
Cold weather exercise and airway cytokine expression
J Appl Physiol, June 1, 2005; 98(6): 2132 - 2136.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
Z. Csoma, E. Huszar, E. Vizi, G. Vass, Z. Szabo, I. Herjavecz, M. Kollai, and I. Horvath
Adenosine level in exhaled breath increases during exercise-induced bronchoconstriction
Eur. Respir. J., May 1, 2005; 25(5): 873 - 878.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
G.F. Joos and B. O'Connor
Indirect airway challenges
Eur. Respir. J., June 1, 2003; 21(6): 1050 - 1068.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. D. BRANNAN, S. D. ANDERSON, K. GOMES, G. G. KING, H. KIM CHAN, and J. PAUL SEALE
Fexofenadine Decreases Sensitivity to and Montelukast Improves Recovery from Inhaled Mannitol
Am. J. Respir. Crit. Care Med., May 1, 2001; 163(6): 1420 - 1425.
[Abstract] [Full Text]


Home page
J. Appl. Physiol.Home page
H. W. F. M. De Gouw, S. J. Marshall-Partridge, H. Van der Veen, J. G. Van den Aardweg, P. S. Hiemstra, and P. J. Sterk
Role of nitric oxide in the airway response to exercise in healthy and asthmatic subjects
J Appl Physiol, February 1, 2001; 90(2): 586 - 592.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. SUZUKI and A. N. FREED
Heparin Inhibits Eicosanoid Metabolism and Hyperventilation-induced Bronchoconstriction in Dogs
Am. J. Respir. Crit. Care Med., June 1, 2000; 161(6): 1850 - 1854.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. Crapo
Guidelines for Methacholine and Exercise Challenge Testing---1999 . THIS OFFICIAL STATEMENT OF THE AMERICAN THORACIC SOCIETY WAS ADOPTED BY THE ATS BOARD OF DIRECTORS, JULY 1999
Am. J. Respir. Crit. Care Med., January 1, 2000; 161(1): 309 - 329.
[Full Text]


Home page
J. Appl. Physiol.Home page
A. N. Freed, Y. Wang, S. McCulloch, T. Myers, and R. Suzuki
Mucosal injury and eicosanoid kinetics during hyperventilation-induced bronchoconstriction
J Appl Physiol, November 1, 1999; 87(5): 1724 - 1733.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
H. Milgrom and L. M. Taussig
Keeping Children With Exercise-induced Asthma Active
Pediatrics, September 1, 1999; 104 (3): e38 - e38.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. D. BRANNAN, H. KOSKELA, S. D. ANDERSON, and N. CHEW
Responsiveness to Mannitol in Asthmatic Subjects with Exercise- and Hyperventilation-induced Asthma
Am. J. Respir. Crit. Care Med., October 1, 1998; 158(4): 1120 - 1126.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
A. N. Freed, V. Taskar, B. Schofield, and C. Omori
Hyperventilation-induced airway injury and vascular leakage in dogs: effects of alpha 1-adrenergic agonists
J Appl Physiol, December 1, 1997; 83(6): 1884 - 1889.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by the European Respiratory Society.